Literature DB >> 3905964

Early endotoxin tolerance is associated with alterations in bone marrow-derived macrophage precursor pools.

G S Madonna, S N Vogel.   

Abstract

Early endotoxin tolerance has been defined as the transient period after an initial sublethal exposure to LPS during which a normally responsive individual is rendered hyporesponsive. Little is known about the cellular mechanisms that underlie this phenomenon. In this study, an early tolerance system was established by the injection of mice with 25 micrograms of E. coli K235 LPS. Maximal hyporesponsiveness in response to a challenge injection was observed 3 to 4 days after the initial injection, and normal responsiveness returned by 8 days after the initial exposure to LPS. Further experiments described herein demonstrate that the acquisition and maintenance of the tolerant state coincides temporally with an increase in the number of macrophage progenitor cells in the bone marrow. Cell-sizing profiles of the bone marrow cells from tolerized mice indicate an enrichment for a population of cells that are significantly larger than in bone marrow preparations from control mice. By density gradient sedimentation, it was shown that the denser population of cells from tolerized mice contained the increased numbers of progenitor cells, which, by cytology, were immature monocytic cell types. The increased numbers of macrophage progenitors was sustained after a second (challenge) injection of LPS. These results indicate that early endotoxin tolerance is associated with an increase in a population of bone marrow cells that is enriched for macrophage progenitors and suggests the possibility that the lack of responsiveness observed during the hyporesponsive period is related to a failure of these immature cell types to respond to LPS.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3905964

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  20 in total

Review 1.  Bloodstream infections: epidemiology, pathophysiology and therapeutic perspectives.

Authors:  R Salomão; O Rigato; A C Pignatari; M A Freudenberg; C Galanos
Journal:  Infection       Date:  1999 Jan-Feb       Impact factor: 3.553

2.  Hematopoietic stem-progenitor cells restore immunoreactivity and improve survival in late sepsis.

Authors:  Laura Brudecki; Donald A Ferguson; Deling Yin; Gene D Lesage; Charles E McCall; Mohamed El Gazzar
Journal:  Infect Immun       Date:  2011-12-05       Impact factor: 3.441

3.  Differential cytokine induction by doses of lipopolysaccharide and monophosphoryl lipid A that result in equivalent early endotoxin tolerance.

Authors:  B E Henricson; W R Benjamin; S N Vogel
Journal:  Infect Immun       Date:  1990-08       Impact factor: 3.441

4.  An interleukin-1 receptor antagonist blocks lipopolysaccharide-induced colony-stimulating factor production and early endotoxin tolerance.

Authors:  B E Henricson; R Neta; S N Vogel
Journal:  Infect Immun       Date:  1991-03       Impact factor: 3.441

5.  Functional lipopolysaccharide receptors of low affinity are constitutively expressed on mouse bone marrow cells.

Authors:  R Girard; T Pedron; R Chaby
Journal:  Immunology       Date:  1997-07       Impact factor: 7.397

6.  Induction of early-phase endotoxin tolerance in athymic (nude) mice, B-cell-deficient (xid) mice, and splenectomized mice.

Authors:  G S Madonna; S N Vogel
Journal:  Infect Immun       Date:  1986-09       Impact factor: 3.441

7.  Recombinant interleukin-1 alpha and recombinant tumor necrosis factor alpha synergize in vivo to induce early endotoxin tolerance and associated hematopoietic changes.

Authors:  S N Vogel; E N Kaufman; M D Tate; R Neta
Journal:  Infect Immun       Date:  1988-10       Impact factor: 3.441

8.  Differential myelopoietic responsiveness of BALB/c (Itys) and C.D2 (Ityr) mice to lipopolysaccharide administration and Salmonella typhimurium infection.

Authors:  V M Peterson; G S Madonna; S N Vogel
Journal:  Infect Immun       Date:  1992-04       Impact factor: 3.441

9.  Toll-like receptor 2- and 6-mediated stimulation by macrophage-activating lipopeptide 2 induces lipopolysaccharide (LPS) cross tolerance in mice, which results in protection from tumor necrosis factor alpha but in only partial protection from lethal LPS doses.

Authors:  Ursula Deiters; Marina Gumenscheimer; Chris Galanos; Peter F Mühlradt
Journal:  Infect Immun       Date:  2003-08       Impact factor: 3.441

10.  Early-phase endotoxin tolerance: induction by a detoxified lipid A derivative, monophosphoryl lipid A.

Authors:  G S Madonna; J E Peterson; E E Ribi; S N Vogel
Journal:  Infect Immun       Date:  1986-04       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.